The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. - Wikidata - awgldk - TriplyDB

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

http://www.wikidata.org/entity/Q33743664

about

Human malarial disease: a consequence of inflammatory cytokine release Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases Sepsis and disseminated intravascular coagulation Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation Inflammasome activation of IL-1 family mediators in response to cutaneous photodamage Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or Action PAMPs and DAMPs as triggers for DIC Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism RAGE controls activation and anti-inflammatory signalling of protein C Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation Targeting HMGB1 in inflammation UVB irradiation regulates ERK1/2- and p53-dependent thrombomodulin expression in human keratinocytes Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.Alarmins: awaiting a clinical response Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion.G-protein coupled receptor 15 mediates angiogenesis and cytoprotective function of thrombomodulin.Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Alarmins, inflammasomes and immunity.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.DAMPening inflammation by modulating TLR signalling.Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy.Toll-like receptor 4 and high-mobility group box 1 are critical mediators of tissue injury and survival in a mouse model for heatstroke.HMGB1 contributes to kidney ischemia reperfusion injury.Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.HMGB1 in health and disease.Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.

P2860

Q21034098-17E3BF12-1D0D-4121-A46E-73115E1018F0 Q26744644-14DA9B40-218F-4578-893C-0122EF269D15 Q26751555-7FE450B2-4656-4576-BC23-F509FC968BF4 Q26992200-ED51AC24-6028-4AAA-818F-9CDBAEBAB58B Q26999689-EF3379BD-23BE-42AF-BDA2-E46A0DA4D557 Q27009468-ACA9F91D-970F-48F4-A9E2-49B1527F1328 Q27013790-D9854DF8-0DBF-47FC-8B30-277A07EE8823 Q27025545-107B9436-F6C1-4C14-960C-069EDC0E427E Q27304989-55DFBEEB-1B92-4983-A622-4114876420CD Q27320852-535EA367-8AA5-4B3F-9179-E772466A2C35 Q28076547-B17AE81F-E57A-4599-9292-40F81E30A50D Q28266138-42F199A8-AA98-4899-9B6B-D75D86A66023 Q28385017-B92AE7E7-0DF7-4A3C-8ACA-D2D697D5AD60 Q28395139-7DAFDF02-EE02-416E-AD75-1C8046446240 Q28590453-34344B88-8E86-42DE-92F6-10024C77CE34 Q28828482-50286827-52C4-4D64-BCEC-CE9A9AAE6B39 Q30489456-4104106D-8A01-4EAF-A435-495D5B931295 Q30523797-F65DE96A-6049-40F1-A260-A7EB8F61CB2C Q33393685-D9BECDC7-8063-4260-BD8E-FE1D902A5DE2 Q33428744-985D6558-C227-4DA1-9885-A98C4858C50A Q33441895-4A088910-177C-425D-8B7B-7FFC244216E8 Q33609776-E1C41A47-3D7D-447E-82BB-72F23998236D Q33612689-6BFCFE37-5B8A-4927-A222-B62CC3C21693 Q33612700-C80E6DAF-2A65-45EC-B662-2F4561249359 Q33677636-0A5C2E26-68DC-4A08-8E0B-A2F066E878F2 Q33751106-5FDE8D59-2191-4C77-A9DE-4B531A77EC0F Q33814903-4F7E4B70-B850-48F6-8193-ED79C987B007 Q33817302-C1B4BEA4-68F9-4AA2-8F03-6976BF798120 Q33836853-F383F6DA-D1AF-4801-A13F-A8BAB7BF434F Q33941922-FC4455BB-8B81-4F6A-8581-98212E4CE628 Q34035570-56B644A5-EEDB-4511-9D11-3F0E5117E8EF Q34074200-F7BC3817-0CC7-4309-AC16-922BBCDF4E09 Q34203942-E9DF71BC-B9D5-45D2-955E-D3E956D12D36 Q34232527-8181D353-903C-4164-9018-8F4CAA8F2D6D Q34409793-C6E3C88B-CD9A-495B-A959-198EE931C4CB Q34457038-2D0FCCE5-F841-4394-90FB-A8C791A72074 Q34501341-336154B3-73B1-44A4-99E8-8CC1D8D892D2 Q34622835-E43D2E86-7C56-4B6D-B863-FD8F615A71C9 Q34737543-EB147A6B-3FA0-4D90-940E-99537BA19BBD Q34932581-FEF0CA9C-0612-4F3F-A297-54E26888B0E5

P2860

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

http://www.wikidata.org/entity/Q33743664

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@ast

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@en

type

label

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@ast

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@en

prefLabel

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@ast

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@en

P1433

Q33743664-6EC66439-F8B3-4AC2-BCFD-8D6496E9CE73

P1476

Q33743664-D6569535-7DFA-480F-8CCF-F604CE24839C

P2093

Q33743664-1F98BB69-A2F9-4371-80C4-7380E435894B

Q33743664-28A5BB8C-E253-45D2-8CA2-F321F7FE8C2D

Q33743664-3CEA490E-613B-4FB8-9A16-DD5C56EE0273

Q33743664-52155F82-2FCC-4DD0-9611-532627E93955

Q33743664-61DC469E-11AA-453C-AA13-92CEDD2E5DD8

Q33743664-67A91870-AECF-436E-A792-E63C0B66170B

Q33743664-89575572-F634-493B-A5C3-7226C9DE78F6

Q33743664-9D604B95-61B8-4C50-841B-31169A9B478A

Q33743664-A2219CED-9031-4AA0-BB17-625BBB934C44

Q33743664-A28368BF-0F95-42E0-8B88-E8313DD5D677

P2860

Q33743664-0A8342F8-13A4-45B5-BB7D-4A114D0A7923

Q33743664-13597B5A-0B82-45D9-972C-FCF24FB2DFE6

Q33743664-2ADC02F2-CCDB-43F5-9C1E-EA5A75FBEB4D

Q33743664-382436F1-82F0-47AA-8EF3-1A983693F4D6

Q33743664-394ECF49-1A33-4A2C-8AB5-692879401CC8

Q33743664-4383BA18-7D5D-4997-9719-91E0CBDC8EF3

Q33743664-57112F6A-3E76-4E6C-B2A4-AE4C26FBCFDD

Q33743664-6786E53C-EA0F-4EDC-A4F9-3CFBE5C90CCE

Q33743664-6EAE8E7B-AB27-49AB-A113-C41616AED4C4

Q33743664-75E5E5F5-5515-4602-B628-2937DFF2804E

P304

Q33743664-A013CE94-D45D-49F8-99EB-6CB55C07F353

P31

Q33743664-DD27514C-1936-40ED-A8AA-429979A04FF8

P356

Q33743664-231C0CCD-8281-419F-A437-D2B4E9E7BE34

P407

Q33743664-C323F9EF-774D-4A1D-BC83-D52737ECF5A9

P433

Q33743664-2DA54961-C109-4800-915F-C8D5B6913ACB

P478

Q33743664-3B8C68DE-D3CA-45C9-A37F-4EF61F93F9BA

P577

Q33743664-2804C5D2-7CCF-415F-ABD4-F07C54C4F283

P698

Q33743664-6B509162-3A83-4B90-8193-22502C9E3417

P932

Q33743664-44BAB832-3FE0-43B5-9C93-E0D45B41FE05

P356

P1433

Journal of Clinical Investigation

P1476

The N-terminal domain of throm ...... el antiinflammatory mechanism.

@en

P2093

David M Stern

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ikuro Maruyama

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Abeyama

http://www.w3.org/2001/XMLSchema#string

Ko-ichi Kawahara

http://www.w3.org/2001/XMLSchema#string

Motoyuki Tanaka

http://www.w3.org/2001/XMLSchema#string

Noboru Taniguchi

http://www.w3.org/2001/XMLSchema#string

Nobuo Ida

http://www.w3.org/2001/XMLSchema#string

Satoshi Iino

http://www.w3.org/2001/XMLSchema#string

Shingo Yamada

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

The roles of protein C and thrombomodulin in the regulation of blood coagulation

Efficacy and safety of recombinant human activated protein C for severe sepsis

Human Fc epsilon RIalpha-specific human single-chain Fv (scFv) antibody with antagonistic activity toward IgE/Fc epsilon RIalpha-binding.

P304

1267-1274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI22782

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15841214

http://www.w3.org/2001/XMLSchema#string

P932

1077171

http://www.w3.org/2001/XMLSchema#string